AF
ASND icon

Allworth Financial’s Ascendis Pharma A/S ASND Stock Holding History

Allworth Financial’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64K Buy
240
+122
+103% +$28.5K ﹤0.01% 2271
2026
Q1 		$27K Buy
118
+107
+973% +$24K ﹤0.01% 2780
2025
Q4 		$2.35K Sell
11
-3
-21% -$620 ﹤0.01% 4059
2025
Q3 		$2.78K Buy
14
+4
+40% +$746 ﹤0.01% 3852
2025
Q2 		$1.73K Buy
+10
New +$1.63K ﹤0.01% 3771
2025
Q1 		– Sell
-2
Closed -$252 – 4064
2024
Q4 		$252 Hold
2
– – ﹤0.01% 3746
2024
Q3 		$299 Buy
+2
New +$270 ﹤0.01% 3524

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Allworth Financial's ASND Position: Q2 2026 in Review

Allworth Financial increased its Ascendis Pharma A/S (ASND) stake by 103% in Q2 2026, buying an estimated $28.5K and bringing the position to 240 shares worth $64K. The position accounts for ﹤0.01% of the portfolio, ranked #2271.

Allworth Financial first reported a position in ASND in Q3 2024 and has held it in 7 quarters since. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Allworth Financial held 240 shares of Ascendis Pharma A/S worth $64K as of Q2 2026.
  • Allworth Financial bought 122 Ascendis Pharma A/S shares in Q2 2026, an estimated $28.5K.
  • Ascendis Pharma A/S made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2271 holding.
  • Allworth Financial first reported a position in Ascendis Pharma A/S in Q3 2024 and has held it in 7 quarters since.
  • 311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.